Patents
Sitemap › C07 - Organic chemistry › C07C - Acyclic or carbocyclic compounds › C07C 317 - Sulfones; Sulfoxides
Patents for C07C 317 - Sulfones; Sulfoxides (15,874)
03/2005
03/31/2005CA2521811A1 Haloalkyl containing compounds as cysteine protease inhibitors
03/30/2005EP1519240A2 Organophotoreceptor with charge transport material having bis(9-fluorenone) azine groups
03/30/2005EP1518553A2 Use of nitrate ester compounds for treating pain or providing analgesia
03/30/2005EP1517889A2 Nitrooxyderivatives of cyclooxygenase-2 inhibitors
03/30/2005EP1517886A1 Novel phthalamide derivatives
03/30/2005EP1517731A1 Method for producing specific crystalline modifications of polymorphous substances
03/30/2005CN1602299A Crystals of bicalutamide and process for their production
03/30/2005CN1602298A Synthesis of oxygen-substituted benzocycloheptenes, used as valuable intermediate products for producing tissue-selective oestrogens
03/30/2005CN1602191A Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
03/30/2005CN1602184A Compounds for a controlled release of active molecules
03/30/2005CN1194964C P-methylsulfonyl phenylacrylate derivative and its prepn process and anti-inflammatory effect
03/29/2005US6872852 Polyamine analogues as cytotoxic agents
03/29/2005US6872851 Melatonergic receptors; antiinflammatory agents; anticancer agents
03/29/2005US6872699 Truncated Flk-1 receptor protein, methods of use and a recombinant vector containing a nucleotide encoding the truncated Flk-1 protein
03/24/2005WO2005012220A3 Cycloalkylidene compounds as modulators of estrogen receptor
03/24/2005WO2003028145A3 Graft oligomeric electrolytes
03/24/2005US20050065377 Processes for the preparation of diphenylsulfone compounds
03/23/2005EP1516869A1 Process for enantioselective synthesis of single enantiomers of modafinil by asymmetric oxidation
03/23/2005EP1515951A1 Arylsulfonylhydroxamic acid and amide derivatives and their use as protease inhibitors
03/23/2005EP1515947A1 Fluorinated cycloalkyl-derivatised benzoylguanidines and their use as a medicament
03/23/2005EP1515726A1 Morpholine and tetrahydropyran derivatives and their use as cathepsin inhibitors
03/23/2005CN1597673A Paro methylsulfonyl phongl acrylic acid derivative and its preparation method and antiinflammation action
03/23/2005CN1193986C Phenolic compounds and recording materials containing the same
03/22/2005US6869975 Linked biaryl compounds
03/22/2005CA2225250C Bicyclic amino derivatives and pgd2 antagonist containing the same
03/17/2005WO2005023198A2 Modafinil compositions
03/17/2005WO2004083867A3 Modulators of g protein-coupled formyl peptide receptor-like 2 and their therapeutic use against cell death-related disorders
03/17/2005US20050059729 Substituted cyclic compounds
03/17/2005US20050059713 Antiviral agents for the treatment, preventions, or amelioration of viral infections; for example, 3-Biphenyl-4-yl-(2S)-[(3'-chloro-4'-fluoro-4-hydroxy-biphenyl-3-carbonyl)-amino]-propionic acid methyl ester
03/17/2005US20050059705 May be antagonists of the intrinsic clotting pathway by binding to and inhibiting the function of factor XI or of both factors XI and IX; for example, 2(S)-{[7-(4-tert-Butyl-phenoxy)-1-cyclopentylmethyl-isoquinoline-3-carbonyl]-amino}-3-(5-phenyl-thiophen-2-yl)-propionic acid; anticoagulants
03/17/2005US20050059665 Substituted aryl compounds as novel cyclooxygenase-2 selective inhibitors, compositions and methods of use
03/17/2005US20050059611 such as 3-{4-[1-(4-Cyclohex-1-enylphenyl)-3-(3,5-dichlorophenyl)ureidomethyl]benzoylamino}-2,2-difluoropropionic acid), used for treatment and/or prevention of hyperglycemia, diabetes, lipid metabolism disorders and obesity
03/16/2005EP1513802A1 Alpha-sulfonylamino-acetonitriles
03/16/2005EP1311476B1 Aza-amino acid derivatives (factor x a?-inhibitors 15)
03/16/2005EP1215200B1 Aromatic diamide derivatives or salts thereof, agricultural/horticultural chemicals and method of using the same
03/16/2005CN1596250A Paclitaxel solvates
03/16/2005CN1193011C Method for producing sulfonyl-benzoyl guanidinium salts
03/10/2005US20050053861 Onium salt compound and radiation-sensitive resin composition
03/10/2005US20050051752 Methods using fluorosulfones for extinguishing fire, preventing fire, and reducing or eliminating the flammability of a flammable working fluid
03/10/2005CA2772017A1 Agricultural/horticultural insecticide and method for using the same
03/10/2005CA2535366A1 Cathepsin inhibitors
03/09/2005EP1511723A1 Sulfone liver x-receptor modulators
03/09/2005EP1511722A1 Phenylcyclohexylpropanolamine derivatives, preparation and therapeutic application thereof
03/09/2005EP1511472A2 Compounds useful in the treatment of anthrax and inhibiting lethal factor
03/09/2005CN1192035C Inhibitors of interleukin-1'beta' converting enzyme
03/09/2005CN1192015C Cell adhesion inhibitors
03/09/2005CN1192011C Calcium receptor-active arylalkyl amines
03/09/2005CN1191884C High surface microporous active materials TIQ-6 and METIQ-6 in oxidation reactions
03/08/2005US6864380 Antiinflammatory agents; asthma; antiallergens; autoimmune diseases; antiarthritic agents
03/08/2005US6864290 Statine derivatives for the treatment of Alzheimer's disease
03/08/2005US6864289 Insecticides
03/08/2005US6864254 Kidney diosrders; brain disorders
03/03/2005WO2005019161A1 Cathepsin cysteine protease inhibitors
03/03/2005WO2005019151A1 Ppar modulators
03/03/2005WO2005018529A2 Phenoxiacetic acid derivatives
03/03/2005US20050049437 Efficiently separating 2,4'-dihydroxydiphenylsulfone from a mixture of 4,4'-dihydroxydiphenylsulfone and 2,4'-dihydroxydiphenylsulfone and effectively utilizing phenolsulfonic acid contained in the reaction mixture as raw material
03/03/2005US20050049310 Aryl and heteroaryl compounds, compositions and methods of use
03/03/2005US20050048395 Homopolymer or copolymer of polyhydroxystyrene changes its solubility in an alkali developer by action of an acid; generating an acid by exposure to radiation; bis((4-(1,3-dioxolan-2-yl)cyclohexyl)methylsulfonyl)diazomethane
03/03/2005US20050048108 Using cephalins as complexing agent for gene therapy, diagnosis
03/03/2005CA2536089A1 Ppar modulators
03/03/2005CA2535714A1 Phenoxyacetic acid derivatives
03/03/2005CA2535359A1 Cathepsin cysteine protease inhibitors
03/02/2005EP1509497A1 Calcium receptor modulating arylalkylamines
03/02/2005CN1191230C Method for preparing neurainidase inhibitor RO-64-0796
03/01/2005US6861562 Comprising heating trihydroxytriphenyldisulfone or a mixture of dihydroxydiphenylsulfone isomers containing trihydroxytriphenyldisulfone in the presence of phenol and an acid catalyst
03/01/2005US6861557 Process for preparing rac-bicalutamide and its intermediates
02/2005
02/24/2005WO2005016915A1 Piperidine/cyclohexane carboxamide derivatives for use as vanilloid receptor modulators
02/24/2005WO2005016862A1 Substituted arylalkanoic acid derivative and use thereof
02/24/2005US20050043371 Aminoalcohol derivatives and their use as beta 3 adrenergic agonists
02/24/2005CA2535665A1 Substituted arylalkanoic acid derivative and use thereof
02/23/2005EP1507756A1 Ccr9 inhibitors and methods of use thereof
02/23/2005EP1041980B1 Acyl guanidine sodium/proton exchange inhibitors and method
02/23/2005EP0929519B1 Beta-sulfonyl hydroxamic acids as matrix metalloproteinases inhibitors
02/23/2005CN1585746A Beta-amyloid protein production/secretion inhibitors
02/23/2005CN1585745A Hydroxyfattysulfonic acid analogs
02/23/2005CN1585742A Aryl aniline beta-2 adrenergic receptor agonists
02/23/2005CN1585638A Linked biaryl compounds
02/23/2005CN1585633A Phenethanolamine derivatives for treatment of respiratory diseases
02/23/2005CN1583720A Synthesis of 4-substrated aryl-1-benzenesulfonyl-3-butylene-2-one
02/23/2005CN1583696A Preparation of bisphenols salts
02/23/2005CN1190406C Method for producing ortho-alkylated benzoic acid derivatives.
02/22/2005US6858691 Exhibit extensive delocalization of the negative charge and good activity in polymerization or in copolymerization and allow the preparation of macromolecules possessing dissociated and stable ionic functional groups
02/22/2005US6858644 Use as anti-tumor agents; examples of solvents are N-methyl-2-pyrrolidone and acetonitrile
02/22/2005US6858639 3-Arylphenyl sulfide derivative and insecticide and miticide
02/22/2005US6858565 Color developers; recording images
02/22/2005CA2200930C Process for preparing .alpha. -haloacetophenone derivative
02/17/2005WO2005014534A1 Aryl and heteroaryl compounds, compositions, and methods of use
02/17/2005WO2005014533A2 Aryl and heteroaryl compounds, compositions, and methods of use
02/17/2005WO2005014532A1 Aryl and heteroaryl compounds, compositions and methods of use
02/17/2005WO2005014531A1 Process for production of n-methacryloyl-4-cyano-3- trifluoromethylaniline, method for stabilization of the same, and process for production of bicalutamide
02/17/2005WO2004002491A8 Morpholine and tetrahydropyran drivatives and their use as cathepsin inhibitors
02/17/2005US20050038259 Elastase release inhibitors; such as 19-(1H-tetrazol-5-yl)nonadec-6-en-5-ol
02/17/2005US20050038124 Highly pure modafinil
02/17/2005US20050038119 for treatment of neutrofil-dependent pathologies such as psoriasis, ulcerative colitis, melanoma, chronic obstructive pulmonary disease (COPD), bollous pemphigo, rheumatoid arthritis, idiopathic fibrosis, glomerulonephritis; prevention and treatment of damages caused by ischemia and reperfusion
02/17/2005US20050038028 Hydroxyethylene compounds with asp2 inhibitory activity
02/17/2005US20050038002 Bactericides; antitumor agents; moderators of gene expression; viricides; parasiticides; malaria therapy
02/17/2005US20050034652 Crystalline forms of modafinil
02/17/2005CA2531796A1 Aryl and heteroaryl compounds, compositions, and methods of use
02/16/2005EP1506958A1 Process for producing shogaol and intermediates for the synthesis thereof
02/16/2005EP1506171A1 Preparations of a sulfinyl acetamide
1 ... 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 ... 159